The Bespoke Gene Therapy Consortium: Exploring the Initiative

Time: 2:00 pm
day: Day Two


  • Outlining the structure of the Consortium and its goals
  • Understanding how to define minimal critical quality attributes through the use of animal toxicology studies
  • Exploring the long-term implications for rare disease in having an internationally harmonised approach